ATE213725T1 - Anilinopeptid-derivate - Google Patents
Anilinopeptid-derivateInfo
- Publication number
- ATE213725T1 ATE213725T1 AT97934472T AT97934472T ATE213725T1 AT E213725 T1 ATE213725 T1 AT E213725T1 AT 97934472 T AT97934472 T AT 97934472T AT 97934472 T AT97934472 T AT 97934472T AT E213725 T1 ATE213725 T1 AT E213725T1
- Authority
- AT
- Austria
- Prior art keywords
- lower alkyl
- independently
- triazol
- salt
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Cosmetics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH178896 | 1996-07-17 | ||
| PCT/EP1997/003804 WO1998003476A1 (en) | 1996-07-17 | 1997-07-16 | Anilinopeptide derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE213725T1 true ATE213725T1 (de) | 2002-03-15 |
Family
ID=4218620
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97934472T ATE213725T1 (de) | 1996-07-17 | 1997-07-16 | Anilinopeptid-derivate |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6451973B1 (de) |
| EP (1) | EP0915841B1 (de) |
| JP (1) | JP4100710B2 (de) |
| AT (1) | ATE213725T1 (de) |
| AU (1) | AU3767797A (de) |
| DE (1) | DE69710731T2 (de) |
| DK (1) | DK0915841T3 (de) |
| ES (1) | ES2173466T3 (de) |
| PT (1) | PT915841E (de) |
| WO (1) | WO1998003476A1 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT915841E (pt) * | 1996-07-17 | 2002-08-30 | Novartis Ag | Derivados anilinopeptidos |
| BR0214748A (pt) | 2001-12-05 | 2004-11-23 | Ortho Mcneil Pharm Inc | Derivados 6-oacil-cetolidas de eritromicina, úteis como antibacterianos |
| CA2549228C (en) | 2003-12-11 | 2013-03-19 | Abbott Laboratories | Hiv protease inhibiting compounds |
| ATE539074T1 (de) * | 2003-12-11 | 2012-01-15 | Abbott Lab | Die hiv-protease hemmende verbindungen |
| EP2069303B1 (de) | 2006-07-21 | 2016-03-30 | Gilead Sciences, Inc. | Antivirale proteasehemmer |
| WO2011080562A1 (en) | 2009-12-29 | 2011-07-07 | Hetero Research Foundation | Novel aza-peptides containing 2,2-disubstituted cyclobutyl and/or substituted alkoxy benzyl derivatives as antivirals |
| JOP20180009A1 (ar) | 2017-02-06 | 2019-01-30 | Gilead Sciences Inc | مركبات مثبط فيروس hiv |
| TWI829205B (zh) | 2018-07-30 | 2024-01-11 | 美商基利科學股份有限公司 | 抗hiv化合物 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4556654A (en) | 1983-06-28 | 1985-12-03 | Warner-Lambert Company | Antimicrobial substituted anthra[1,9-cd]pyrazol-6(2H)-ones |
| IE913840A1 (en) | 1990-11-20 | 1992-05-20 | Abbott Lab | Retroviral protease inhibiting compounds |
| US5753652A (en) * | 1991-07-03 | 1998-05-19 | Novartis Corporation | Antiretroviral hydrazine derivatives |
| WO1993018006A1 (en) | 1992-03-11 | 1993-09-16 | Narhex Limited | Amine derivatives of oxo- and hydroxy-substitued hydrocarbons |
| DK0604368T3 (de) | 1992-12-23 | 1997-02-24 | Ciba Geigy Ag | |
| DK0727419T3 (da) | 1992-12-29 | 2002-06-10 | Abbott Lab | Mellemprodukter til fremstilling af forbindelser, som inhiberer retroviral protease |
| US5461067A (en) | 1993-02-25 | 1995-10-24 | Abbott Laboratories | Retroviral protease inhibiting compounds |
| ATE220661T1 (de) | 1994-10-19 | 2002-08-15 | Novartis Erfind Verwalt Gmbh | Antivirale ether von aspartat-protease-substrat- isosteren |
| US5849911A (en) * | 1996-04-22 | 1998-12-15 | Novartis Finance Corporation | Antivirally active heterocyclic azahexane derivatives |
| PT915841E (pt) * | 1996-07-17 | 2002-08-30 | Novartis Ag | Derivados anilinopeptidos |
-
1997
- 1997-07-16 PT PT97934472T patent/PT915841E/pt unknown
- 1997-07-16 DK DK97934472T patent/DK0915841T3/da active
- 1997-07-16 EP EP97934472A patent/EP0915841B1/de not_active Expired - Lifetime
- 1997-07-16 WO PCT/EP1997/003804 patent/WO1998003476A1/en active IP Right Grant
- 1997-07-16 AT AT97934472T patent/ATE213725T1/de active
- 1997-07-16 JP JP50653898A patent/JP4100710B2/ja not_active Expired - Lifetime
- 1997-07-16 US US09/214,959 patent/US6451973B1/en not_active Expired - Lifetime
- 1997-07-16 DE DE69710731T patent/DE69710731T2/de not_active Expired - Lifetime
- 1997-07-16 ES ES97934472T patent/ES2173466T3/es not_active Expired - Lifetime
- 1997-07-16 AU AU37677/97A patent/AU3767797A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP4100710B2 (ja) | 2008-06-11 |
| PT915841E (pt) | 2002-08-30 |
| WO1998003476A1 (en) | 1998-01-29 |
| EP0915841A1 (de) | 1999-05-19 |
| EP0915841B1 (de) | 2002-02-27 |
| DE69710731D1 (de) | 2002-04-04 |
| US6451973B1 (en) | 2002-09-17 |
| AU3767797A (en) | 1998-02-10 |
| DK0915841T3 (da) | 2002-06-10 |
| DE69710731T2 (de) | 2002-10-24 |
| JP2000515147A (ja) | 2000-11-14 |
| ES2173466T3 (es) | 2002-10-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE150308T1 (de) | Hemmung von thrombin | |
| DK0558673T3 (da) | Retrovirale proteaseinhibitorer | |
| DE69420564D1 (de) | Immunsuppressive und antiallergische verbindungen; z.b. n-(3-oxohexanoyl)-homoserinlacton | |
| UA26930C2 (uk) | Засіб для іhгібуваhhя еhдометріозу | |
| DK0554400T3 (da) | Retrovirale proteaseinhibitorer | |
| MX9701325A (es) | Metodos para inhibir la mucositis ulcerativa. | |
| DE69402165D1 (de) | Hemmung von Seborrhoe und Akne | |
| ATE260104T1 (de) | Hemmung der endprodukte fortgeschrittener glykolisierung | |
| NO943874L (no) | Behandling av resistant neoplasma | |
| DE69710731D1 (de) | Anilinopeptid-derivate | |
| UA26459C2 (uk) | Іhгібітор впливу амілоїдhих білків | |
| DE69427807D1 (de) | Hemmung von Hirsutismus und Alopecia bei Frauen | |
| NO942668D0 (no) | Alkylderivater av trazodon med CNS-aktivitet |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |